Applied Therapeutics (APLT): Debts to Book Capitalization

Stable demand for rare disease therapies creates a solid profit foundation, which, upon verifying the financial leverage of Applied Therapeutics (APLT) on GURU.Markets, is reflected in the capital dynamics. The value of 0.00 shows the most recent figure for this metric. Strict transportation control guarantees supply reliability, while the anticipation of FDA verdicts on new drugs, with losses already priced in, determines the current development vector.

This indicator measures the share of total liabilities relative to equity based on current market prices. By analyzing the total debt-to-equity coverage ratio, an investor assesses the risk of excessive leverage. For Applied Therapeutics (APLT), this confirms financial autonomy during the period of awaiting drug approvals. An ethical image and community loyalty support the capitalization, reducing reliance on borrowings. The asset demonstrates high structural resilience.